OPGx MERTK

N/A

Report date: 2025/03/07 17:07:58

Base Information

Drug NameOPGx MERTK
Drug Alias NameOPGx MERTKOPGx-MERTK
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transferenceTyrosine-protein kinase Mer inhibitors
TargetsTyrosine-protein kinase Mer
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOpus Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOpus Genetics Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A